ArticleDigital health
The minimum data set for goiter disorder in Iran.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective: Goiter, primarily caused by iodine deficiency, remains one of the most common endocrine disorders globally. The absence of standardized and structured data hampers effective monitoring, diagnosis, and management. This study aimed to develop a minimum data set (MDS) for goiter to facilitate accurate and consistent data collection and support the development of a national registry system for improved healthcare delivery. Methods: A cross-sectional study was conducted in Kerman, Iran, from October 2023 to May 2024, in three phases. In the first phase, relevant data elements were extracted from the literature and existing records. In the second phase, a checklist was designed based on the extracted elements. In the third phase, a two-round Delphi method was conducted with a panel of domain experts, including endocrinologists and health informatics specialists, to validate and finalize the proposed MDS. Results: Initially, 57 data elements were identified across clinical and managerial categories. After the first Delphi round, 15 elements were approved. Following the second round, the final MDS was refined to 9 core elements that met the experts' consensus. Conclusion: This study demonstrates that a carefully designed MDS, developed with input from both clinical and informatics experts, can significantly enhance the quality and consistency of goiter-related data. It supports better planning, resource allocation, and clinical outcomes while addressing existing challenges such as poor registration systems and lack of standardized documentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.